PACE-CME

Colchicine fails to reduce perioperative AF or MI in patients undergoing major thoracic surgery

Colchicine fails to reduce perioperative AF or MI in patients undergoing major thoracic surgery
RestartResume
3' education - Aug. 26, 2023 - David Conen, MD
  • Overview

    ESC Congress 2023 David Conen presents the results of the COP-AF trial that demonstrated that colchicine did not reduce the incidence on perioperative AF or myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery. However, there were promising trends across multiple secondary and post-hoc outcomes.

  • Educational information

    This video was recorded during the ESC Congress 2023 in Amsterdam, The Netherlands.

  • Faculty

    David Conen,MD is internist and cardiologist. He is Scientist and Principal Investigator at the Population Health Research Institute, McMaster University in Hamilton, ON, Canada, where he holds an appointment as Associate Professor, Department of Medicine.

  • Disclosures

Facebook Comments

Register

We’re glad to see you’re enjoying PACE-CME…
but how about a more personalized experience?

Register for free